EMBL-EBI | Chemical Biology | ChEBI
Example searches: iron*, InChI=1S/CH4O/c1-2/h2H,1H3, caffeine | Advanced Search
| Formula | C8H13NO2 |
| Net Charge | 0 |
| Average Mass | 155.197 |
| Monoisotopic Mass | 155.09463 |
| SMILES | COC(=O)C1=CCCN(C)C1 |
| InChI | InChI=1S/C8H13NO2/c1-9-5-3-4-7(6-9)8(10)11-2/h4H,3,5-6H2,1-2H3 |
| InChIKey | HJJPJSXJAXAIPN-UHFFFAOYSA-N |
| Wikipedia |
|---|
| Roles Classification |
|---|
| Biological Roles: | metabolite Any intermediate or product resulting from metabolism. The term 'metabolite' subsumes the classes commonly known as primary and secondary metabolites. muscarinic agonist Any drug that binds to and activates a muscarinic cholinergic receptor. metabolite Any intermediate or product resulting from metabolism. The term 'metabolite' subsumes the classes commonly known as primary and secondary metabolites. |
| Application: | muscarinic agonist Any drug that binds to and activates a muscarinic cholinergic receptor. |
| ChEBI Ontology |
|---|
| Outgoing Relation(s) |
| arecoline (CHEBI:2814) has role metabolite (CHEBI:25212) |
| arecoline (CHEBI:2814) has role muscarinic agonist (CHEBI:38325) |
| arecoline (CHEBI:2814) is a enoate ester (CHEBI:51702) |
| arecoline (CHEBI:2814) is a methyl ester (CHEBI:25248) |
| arecoline (CHEBI:2814) is a pyridine alkaloid (CHEBI:26416) |
| arecoline (CHEBI:2814) is a tetrahydropyridine (CHEBI:26921) |
| IUPAC Name |
|---|
| methyl 1-methyl-1,2,5,6-tetrahydropyridine-3-carboxylate |
| Synonyms | Source |
|---|---|
| arekolin | ChEBI |
| arecaidine methyl ester | ChEBI |
| arecaline | ChEBI |
| methylarecaiden | ChEBI |
| methylarecaidin | ChEBI |
| arecholine | ChEBI |
| Manual Xrefs | Databases |
|---|---|
| C10129 | KEGG COMPOUND |
| CN102464607 | Patent |
| CN101411705 | Patent |
| HMDB0030353 | HMDB |
| DB04365 | DrugBank |
| US2506458 | Patent |
| Arecoline | Wikipedia |
| C00002020 | KNApSAcK |
| LSM-15214 | LINCS |
| Registry Numbers | Sources |
|---|---|
| Reaxys:123045 | Reaxys |
| CAS:63-75-2 | KEGG COMPOUND |
| CAS:63-75-2 | ChemIDplus |
| Citations |
|---|